AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,830.00
-150.00 (-1.88%)
Jun 5, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Product Sales (ODM)
209.82M
Log In
Log In
Log In
Log In
Upgrade
Product Sales (General)
61.74M
Log In
Log In
Log In
Log In
Upgrade
Reagent
52.31M
Log In
Log In
Log In
Log In
Upgrade
Reagent Growth
8.19%
Log In
Log In
Log In
Log In
Upgrade
Services
-
Log In
Log In
Log In
Log In
Upgrade
Services Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
South Korea
323.87M
Log In
Log In
Log In
Log In
Upgrade
South Korea Growth
569.80%
Log In
Log In
Log In
Log In
Upgrade